Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,495 | -11,241 | -7,427 | -3,613 | -9,458 |
| Depreciation Amortization | 13 | 10 | 6 | 3 | 11 |
| Accounts payable and accrued liabilities | 1,035 | 515 | -54 | 111 | 657 |
| Other Working Capital | -780 | -477 | -1,785 | -128 | 834 |
| Other Operating Activity | 689 | 892 | 954 | 319 | 638 |
| Operating Cash Flow | $-13,538 | $-10,302 | $-8,306 | $-3,308 | $-7,318 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -4 | -4 | -4 | -18 |
| Investing Cash Flow | $-6 | $-4 | $-4 | $-4 | $-18 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,987 | 4,987 | 1,418 | 478 | 14,222 |
| Other Financing Activity | -478 | -395 | -262 | -130 | -88 |
| Financing Cash Flow | $4,509 | $4,592 | $1,156 | $347 | $14,134 |
| Beginning Cash Position | 14,040 | 14,040 | 14,040 | 14,040 | 7,241 |
| End Cash Position | 5,005 | 8,326 | 6,886 | 11,075 | 14,040 |
| Net Cash Flow | $-9,035 | $-5,713 | $-7,154 | $-2,964 | $6,798 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,538 | -10,302 | -8,306 | -3,308 | -7,318 |
| Capital Expenditure | -6 | -4 | -4 | -4 | -18 |
| Free Cash Flow | -13,544 | -10,305 | -8,310 | -3,312 | -7,336 |